Reaction Details Report a problem with these data
Target
Kallikrein-1
Ligand
BDBM408705
Substrate
n/a
Meas. Tech.
Inhibitory Activity In Vitro Assay
IC50
>10000±n/a nM
Citation
 Davie, RL; Edwards, HJ; Evans, DM; Hodgson, ST N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors US Patent  US10364238 Publication Date 7/30/2019 
Target
Name:
Kallikrein-1
Synonyms:
KLK1 | KLK1_HUMAN | Kallikrein 1 | Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein
Type:
Enzyme
Mol. Mass.:
28874.69
Organism:
Homo sapiens (Human)
Description:
P06870
Residue:
262
Sequence:
MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS
  
Inhibitor
Name:
BDBM408705
Synonyms:
1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-3-(trifluoromethyl)-N-[(2,4,6- trimethylphenyl)methyl]pyrazole-4-carboxamide | US10364238, Example 26 | US11001578, Example 26 | US11084809, Example 26 | US11198691, Example 26
Type:
Small organic molecule
Emp. Form.:
C27H28F3N5O
Mol. Mass.:
495.5393
SMILES:
Cc1cnn(Cc2ccc(Cn3cc(C(=O)NCc4c(C)cc(C)cc4C)c(n3)C(F)(F)F)cc2)c1
Structure:
Search PDB for entries with ligand similarity: